Results 131 to 140 of about 4,457,527 (301)
The rationale for thrombolytic therapy [PDF]
European Heart Journal, 1996 Substantial progress has been made toward understanding the pathophysiological processes that lead to acute myocardial infarction. Research has shown that the mechanism of infarction is the rupture of an atherosclerotic plaque with a subsequent thrombogenic response from exposed subendothelial tissue, leading to additional or complete obstruction of ...
openaire +3 more sources
Nanomedicine progress in thrombolytic therapy.
Biomaterials, 2020 Alina Zenych +2 more
semanticscholar +1 more source
Thrombolytic Therapy in Haemolytic-Uraemic Syndrome [PDF]
, 1974 J. Stuart +3 more
openalex +1 more source
Letter: Thrombolytic therapy in haemolytic-uraemic syndrome. [PDF]
, 1974 E Ekert
openalex +1 more source
A Comparison of Thrombolytic Therapy and Primary Angioplasty in Patients with Acute Myocardial Infarction [PDF]
Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i BābulBackground and Objective: The standard treatment for patients with acute myocardial infarction is to reestablish blood flow in the blocked vessels, which is possible through angioplasty and thrombolytic therapy. However, even in developed countries, some
MS Ramezani +5 more
doaj
Letter: Thrombolytic therapy in haemolytic-uraemic syndrome. [PDF]
, 1975 J. Stuart, Richard H. White
openalex +1 more source
Racial/Ethnic Differences in Cardiac Care: The Weight of the Evidence [PDF]
, 2002 A substantial and growing body of research indicates that race/ethnicity -- independent of clinical and socioeconomic factors -- continues to matter in the U.S. health care system.
core
پزشکی بالینی ابن سینا, 2005 Acute myocardial infarction (AMI ) is one of the most common cause of mortality in almost all countries of the world. According to this fact that thrombus formation and coronary obstruction are the basic pathophysiology of AMI , early thrombolysis and
Shahram Homayonfar +2 more
doaj
Effectiveness of thrombolytic therapy in patients with severe COVID-19 and pulmonary embolism
Вісник медичних і біологічних дослідженьCurrent research provides insufficient data on the use of thrombolytic therapy in the treatment of pulmonary embolism in patients with COVID-19. Existing studies present data on the efficacy of thrombolytic drug therapy for thrombotic complications in ...
O. Oliinyk
doaj +1 more source
Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? [PDF]
, 1986 Frank Vermeer +9 more
openalex +1 more source